An overview of allergic bronchopulmonary aspergillosis with some new insights.

abstract：:Rhinitis symptom complex consists of rhinorrhea, congestion, itchy mucosa, itchy eyes, and sneezing. Available medications vary in their benefit for each of these symptoms. It was the purpose of this article to compare symptom reduction with three different classes of medications. Montelukast, azelastine, and budesoni...

journal_title：Allergy and asthma proceedings

authors： Sardana N,Santos C,Lehman E,Craig T

更新日期：2010-01-01 00:00:00

abstract：:The HRQL (Health Related Quality of Life) is considered a relevant aspect of pharmacological treatment, since it evaluates the outcomes from the patient's viewpoint. This article reviews the currently available information about HRQL as an outcome measure in Respiratory Allergy. Pertinent abstracts and articles were c...

journal_title：Allergy and asthma proceedings

authors： Baiardini I,Pasquali M,Giardini A,Majani G,Canonica GW

更新日期：2001-05-01 00:00:00

abstract：BACKGROUND:High anxiety has been reported in patients with drug hypersensitivity reaction (DHR); however, its relationship with the test results was not studied previously. OBJECTIVE:We aimed to investigate the association of patient anxiety with the results of drug tests together with the other contributing factors. ...

journal_title：Allergy and asthma proceedings

authors： Comert S,Erdogan T,Demir AU,Karakaya G,Kalyoncu AF

更新日期：2015-11-01 00:00:00

abstract：:The nonallergic rhinitis with eosinophilia syndrome (NARES) is a type of chronic rhinitis, characterized by intense (> 20%) eosinophilia of the nasal secretions. In this study, screening for NARES in 81 patients with nonallergic chronic rhinitis was performed using a modified nasal lavage cytometric method. Twenty-one...

journal_title：Allergy and asthma proceedings

authors： Schiavino D,Nucera E,Milani A,Della Corte AM,D'Ambrosio C,Pagliari G,Patriarca G

更新日期：1997-11-01 00:00:00

abstract：:Background: Allergy immunotherapy (AIT), both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), is an effective and safe treatment for allergic rhinitis and allergic asthma due to inhalant allergens. However, there are many variables in how it is administered. Objective: To review the evidence tha...

journal_title：Allergy and asthma proceedings

authors： Nelson HS

更新日期：2020-01-01 00:00:00

abstract：:Background: Approximately 80% of patients with asthma and chronic obstructive pulmonary disease incorrectly use a metered-dose inhaler and, therefore, fail to obtain full benefit from their inhaler medication. Beclomethasone dipropionate (BDP) hydrofluoroalkane, an inhalation aerosol administered via a breath-actuated...

journal_title：Allergy and asthma proceedings

authors： Mansfield LE,Hampel FC,Sfeir B,Small CJ,Walsh D,Dunphy L

更新日期：2019-05-01 00:00:00

abstract：:Olopatadine hydrochloride ophthalmic solution 0.2% (Pataday, Alcon) is a new formulation of olopatadine hydrochloride ophthalmic solution, the first topical ocular antiallergic agent indicated for once-daily dosing. The aim of this study was to evaluate the safety, efficacy, onset, and duration of action of olopatadin...

journal_title：Allergy and asthma proceedings

authors： Abelson MB,Gomes PJ,Pasquine T,Edwards MR,Gross RD,Robertson SM

更新日期：2007-07-01 00:00:00

abstract：BACKGROUND:Atopic dermatitis (AD) is a chronic inflammatory skin disease. Clusterin is a sensitive cellular biosensor of oxidative stress and has been studied as a marker to assess inflammatory diseases. The clusterin levels in AD have not been evaluated thus far. OBJECTIVE:We evaluated serum clusterin levels in child...

journal_title：Allergy and asthma proceedings

authors： Sol IS,Kim YH,Lee KE,Hong JY,Kim MN,Kim YS,Oh MS,Kim MJ,Yoon SH,Park YA,Kim KW,Sohn MH,Kim KE

更新日期：2016-07-01 00:00:00

abstract：:Mast cells have been implicated in the pathogenesis of allergic diseases and in inflammatory responses associated with pathological immune and disease-related processes including fibrosis, autoimmune pathology, and neoplasia. Recent findings in animal models of bacterial infection also suggest that mast cells may have...

journal_title：Allergy and asthma proceedings

authors： Taylor ML,Metcalfe DD

更新日期：2001-05-01 00:00:00

abstract：:Anti-IgE therapy with omalizumab, a recombinant humanized monoclonal antibody, has anti-inflammatory effects in allergic asthma and rhinitis. Although omalizumab has been exceptionally safe, reactions after its administration have been reported. The goal of this study was to assess two patients who experienced apparen...

journal_title：Allergy and asthma proceedings

authors： Price KS,Hamilton RG

更新日期：2007-05-01 00:00:00

abstract：:Background: Indoor air pollution may have an impact on asthma. Objective: To evaluate the influence of indoor air pollution on the natural history of asthma. Methods: Data collection by using the European Community Respiratory Health Survey and International Study of Asthma and Allergies in Childhood standardized ques...

journal_title：Allergy and asthma proceedings

authors： Piekarska B,Stankiewicz-Choroszucha BL,Sybilski AJ,Furmańczyk K,Jaworski S,Białoszewski AZ,Kłak A,Lipiec A,Walkiewicz A,Tomaszewska A,Raciborski F,Samoliński BK

更新日期：2018-11-01 00:00:00

abstract：:Flunisolide hydrofluoroalkane (HFA) with integrated spacer is the most recent reformulated inhaled corticosteroid (ICS) for asthma available in the United States. It is the only product that combines a corticosteroid extrafine aerosol with a built-in spacer. The potential clinical benefit of the flunisolide HFA formul...

journal_title：Allergy and asthma proceedings

authors： Berger WE,Tashkin DP

更新日期：2015-03-01 00:00:00

abstract：:Fractional exhaled nitric oxide (FeNO) measurement is an important noninvasive tool for evaluating eosinophilic inflammation of the airways. However, measurement of online FeNO in elderly people may not be possible if they are unable to perform the expiratory maneuver. The offline FeNO test is an alternative method th...

journal_title：Allergy and asthma proceedings

authors： Hsu JY,Huang WC,Huang PL,Cheng YW,Chou MC

更新日期：2013-09-01 00:00:00

abstract：:A 64-year-old male patient with a 15-year history of chronic obstructive pulmonary disease presented with an atypical rash that was refractory to standard therapy. Pulmonary function tests confirmed an obstructive lung disease. Basic laboratory workup revealed conflicting information, leading to a diagnostic challenge...

journal_title：Allergy and asthma proceedings

authors： Craig ET,Banta E,Craig TJ

更新日期：2011-07-01 00:00:00

abstract：OBJECTIVE:We evaluated the risk of asthma development in adult patients with inflammatory bowel disease (IBD) in a nationwide population. METHODS:A retrospective cohort study was conducted by using data retrieved from the Taiwan National Health Insurance Research Database. Patients, ages 20 year or older, with newly d...

journal_title：Allergy and asthma proceedings

authors： Peng YH,Liao WC,Su CH,Chen HJ,Hsia TC,Chu CC,Liu CJ,Kao CH

更新日期：2015-09-01 00:00:00

abstract：:Background: Although clinical trials documented omalizumab's efficacy in U.S. patients with chronic idiopathic urticaria (CIU), the real-world evidence on its long-term effectiveness is lacking. Objective: To assess omalizumab use and the long-term response in a large sample of U.S. real-world patients. Methods: Patie...

journal_title：Allergy and asthma proceedings

authors： Kavati A,Zhdanava M,Ortiz B,LeCocq J,Schiffman B,Pilon D,Ching Cheung H,Lefebvre P,Stone BD

更新日期：2019-09-01 00:00:00

abstract：:The effects of inhaled corticosteroids (ICSs) and long-acting beta 2-agonists (LABAs) on therapeutic targets have significant clinical relevance regarding optimal management of asthma. Asthma pathophysiology involves two main components: smooth muscle dysfunction and airway inflammation. LABAs and ICSs provide complem...

journal_title：Allergy and asthma proceedings

authors： Settipane RA,National Asthma Education and Prevention Program (NAEPP).

更新日期：2003-03-01 00:00:00

abstract：:The cardinal nasal symptoms of allergic rhinitis (AR) are sustained by an underlying inflammatory process. Congestion is one of the most prominent and distressing symptoms for patients and is strongly associated with a broadly deteriorated quality of life and significant losses in productivity. The purpose of this stu...

journal_title：Allergy and asthma proceedings

authors： Marple BF

更新日期：2008-05-01 00:00:00

abstract：:Hereditary angioedema (HAE) is a rare, autosomal dominant, genetic disorder associated with a deficiency in C1 inhibitor protein. HAE is characterized by recurrent and unpredictable episodes of swelling of the extremities, abdomen, face, and upper airway. There are several newly approved drugs as well as investigation...

journal_title：Allergy and asthma proceedings

authors： Barmettler S,Li Y,Banerji A

更新日期：2019-01-01 00:00:00

abstract：:The symptoms of allergic rhinitis vary in severity over the course of the day and often are worse in the morning. This review focuses on data from clinical studies of the antihistamine desloratadine to establish whether it effectively controls the morning symptoms of allergic rhinitis. Studies of desloratadine in pati...

journal_title：Allergy and asthma proceedings

authors： Schenkel EJ

更新日期：2006-11-01 00:00:00

abstract：BACKGROUND:A history of penicillin allergy is associated with an increased risk of nosocomial infections because patients are exposed to non-beta lactam antibiotics. Ruling out inaccurate penicillin allergy during hospitalization decreases prescription of beta lactam antibiotics. However, the utilization of penicillin ...

journal_title：Allergy and asthma proceedings

authors： Sacco KA,Chirila R,Libertin C,Hiroto B,Bhasin A,Johnson MM,Pongdee T,Burton MC

更新日期：2018-05-01 00:00:00

abstract：PURPOSE:An association between childhood allergic disease and parental psychological disorders has been reported. However, little is known about the relationship between childhood allergic disease and maternal depression. This study was performed to determine if there is an association between childhood allergic diseas...

journal_title：Allergy and asthma proceedings

authors： Kim CH,Kim SH,Lee JS

更新日期：2017-07-01 00:00:00

abstract：:The atopy patch test (APT) was first reported in 1895 by the German dermatologist, Jadassohn and was used for evaluation of contact dermatitis. The first documented epicutaneous application of aeroallergens was by Rostenberg and Sulzbergen in 1937. Although others including Mitchell and Platts-Mills, further described...

journal_title：Allergy and asthma proceedings

authors： Edwards KP,Martinez BA

更新日期：2014-11-01 00:00:00

abstract：:The practicing allergist has the unique opportunity to see an extraordinary variety of fascinating patients. Identifying the precise cause of the patient's complaints makes for a satisfying intellectual endeavor. This is exemplified by the description of nine cases seen in a university allergy clinic. The cases includ...

journal_title：Allergy and asthma proceedings

authors： Slavin RG

更新日期：2008-07-01 00:00:00

abstract：BACKGROUND:Asthma guidelines recommend periodic assessment of impairment and risk factors to prevent exacerbations, which can lead to hospitalization and increased health care utilization and cost. According to recent meta-analysis data, fractional exhaled nitric oxide (FeNO) monitoring is associated with a 40-50% redu...

journal_title：Allergy and asthma proceedings

authors： Arnold RJG,Layton A,Massanari M

更新日期：2018-09-13 00:00:00

abstract：:Asthma remains one of the most common diseases worldwide and results in significant societal health care costs and in morbidity and mortality to those afflicted. Despite currently available medications, 5-10% of patients with asthma have severe disease with debilitating symptoms and/or life-threatening exacerbations. ...

journal_title：Allergy and asthma proceedings

authors： Dunn R,Wechsler ME

更新日期：2015-07-01 00:00:00

abstract：:Potentially (near) fatal asthma (PFA) defines a subset of patients with asthma who are at increased risk for death from their disease. The diagnosis of PFA should motivate treating physicians, health professionals, and patients to be more aggressive in the monitoring, treatment, and control of this high-risk type of a...

journal_title：Allergy and asthma proceedings

authors： Greenberger PA

更新日期：2019-11-01 00:00:00

abstract：:Barbiturates, a class of medications commonly used as antiepileptics and sedatives, are known to cause adverse reaction, with the most commonly reported immune-mediated reactions being anticonvulsant hypersensitivity syndrome. Other types of allergic reactions such as immediate hypersensitivity reactions also can occu...

journal_title：Allergy and asthma proceedings

authors： Butte MJ,Dodson B,Dioun A

更新日期：2004-07-01 00:00:00

abstract：:A new nasal aerosol solution formulation of ciclesonide containing a hydrofluoroalkane propellant (CIC-HFA) delivered via a metered-dose inhaler is currently in clinical development as a potential treatment for allergic rhinitis (AR). This study evaluated the efficacy and tolerability of CIC-HFA 74- or 148-microgram d...

journal_title：Allergy and asthma proceedings

authors： Mohar D,Berger WE,Laforce C,Raphael G,Desai SY,Huang H,Hinkle J

更新日期：2012-01-01 00:00:00

abstract：:This randomized, double-blind, parallel, multi-center study was designed to determine whether the addition of salmeterol to existing inhaled corticosteroid therapy provides greater therapeutic benefit than doubling the dose of inhaled corticosteroids in symptomatic patients with asthma. A total of 514 adults were rand...

journal_title：Allergy and asthma proceedings

authors： Murray JJ,Church NL,Anderson WH,Bernstein DI,Wenzel SE,Emmett A,Rickard KA

更新日期：1999-05-01 00:00:00